| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J C Day, C S Tham, H C Fibige. Dopamine depletion attenuates amphetamine-induced increases of cortical acetylcholine release. European journal of pharmacology. vol 263. issue 3. 1995-03-03. PMID:7843266. |
these results point to an important role for forebrain dopamine in the regulation of cortically projecting cholinergic neurons and fail to support the hypothesis that the ascending noradrenergic projections of the locus coeruleus are significantly involved. |
1995-03-03 |
2023-08-12 |
rat |
| J Shaskus, E Zellmer, E J Lewi. A negative regulatory element in the rat dopamine beta-hydroxylase gene contributes to the cell type specificity of expression. Journal of neurochemistry. vol 64. issue 1. 1995-01-24. PMID:7798950. |
dopamine beta-hydroxylase (dbh) catalyzes the synthesis of the neurohormone norepinephrine and is expressed only in noradrenergic and adrenergic cells of the nervous and endocrine systems. |
1995-01-24 |
2023-08-12 |
rat |
| R C Zimmermann, L Krahn, G Klee, P Delgado, S J Ory, S C Li. Inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates nocturnal melatonin secretion in humans. The Journal of clinical endocrinology and metabolism. vol 79. issue 4. 1994-11-29. PMID:7962283. |
the catecholamine dopamine (d) is involved in the regulation of lh and prl secretion, whereas a dysregulated noradrenergic system may contribute significantly to symptoms encountered in affective disorders. |
1994-11-29 |
2023-08-12 |
human |
| K Kim, B J Lee, B N Cho, S S Kang, W S Choi, S D Park, C C Lee, W K Cho, W Wuttk. Blockade of noradrenergic neurotransmission with diethyldithiocarbamic acid decreases the mRNA level of gonadotropin-releasing hormone in the hypothalamus of ovariectomized, steroid-treated prepubertal rats. Neuroendocrinology. vol 59. issue 6. 1994-10-13. PMID:8084377. |
in order to determine whether noradrenergic neurotransmission is involved in the stimulatory effect of p on gnrh gene expression, diethyldithiocarbamic acid (ddc, 500 mg/kg), a dopamine beta-hydroxylase inhibitor was administered i.p. |
1994-10-13 |
2023-08-12 |
rat |
| W Asakura, K Matsumoto, H Ohta, H Watanab. Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacology, biochemistry, and behavior. vol 48. issue 1. 1994-08-10. PMID:7913230. |
these results suggest that rems deprivation treatment-induced increase in swimming activity is mainly due to the functional changes in the dopaminergic system rather than the noradrenergic or serotonergic system, and that dopamine d2 but not d1 receptor mechanism is involved in the increase in swimming activity in rems-deprived animals. |
1994-08-10 |
2023-08-12 |
mouse |
| V Gayrard, B Malpaux, Y Tillet, J C Thiér. Estradiol increases tyrosine hydroxylase activity of the A15 nucleus dopaminergic neurons during long days in the ewe. Biology of reproduction. vol 50. issue 5. 1994-08-05. PMID:7912958. |
in experiment 2, we estimated the relative contribution to the accumulation of l-dopa in the lateral retrochiasmatic area by dopamine (da) synthesis in the dopaminergic neurons and noradrenaline (na) synthesis in the noradrenergic afferents of the a15 nucleus. |
1994-08-05 |
2023-08-12 |
Not clear |
| M A Malone, J R Kershner, J M Swanso. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. Journal of child neurology. vol 9. issue 2. 1994-07-19. PMID:8006372. |
to advance our understanding of attention-deficit hyperactivity disorder and medication effects we draw upon the evidence for (1) a neurotransmitter imbalance between norepinephrine and dopamine in attention-deficit hyperactivity disorder and (2) an asymmetric neural control system that links the dopaminergic pathways to left hemispheric processing and links the noradrenergic pathways to right hemispheric processing. |
1994-07-19 |
2023-08-12 |
Not clear |
| L Pozzi, R Invernizzi, L Cervo, F Vallebuona, R Samani. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. Journal of neurochemistry. vol 63. issue 1. 1994-07-11. PMID:8207428. |
evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. |
1994-07-11 |
2023-08-12 |
rat |
| L Pozzi, R Invernizzi, L Cervo, F Vallebuona, R Samani. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. Journal of neurochemistry. vol 63. issue 1. 1994-07-11. PMID:8207428. |
experiments were performed to confirm that noradrenergic terminals regulate extracellular concentrations of dopamine (da) in the frontal cortex of rats. |
1994-07-11 |
2023-08-12 |
rat |
| L Luts, F Sundle. Peptide-containing nerve fibers in the parathyroid glands of different species. Regulatory peptides. vol 50. issue 2. 1994-06-17. PMID:7514798. |
several neuropeptides, calcitonin gene-related peptide (cgrp), galanin, neuropeptide y (npy), pituitary adenylate cyclase activating peptide (pacap), substance p (sp), vasoactive intestinal polypeptide (vip), the noradrenergic marker dopamine beta-hydroxylase (dbh) and the general neuroendocrine marker pgp 9.5 were localized by immunocytochemistry in the parathyroid glands of chicken, rat, guinea-pig, cat, dog and sheep. |
1994-06-17 |
2023-08-12 |
rat |
| F Amin, T E Seeman, R C Mohs, M Davidson, P Knott, L F Berkman, M Albert, D Blaze. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 10. issue 1. 1994-06-15. PMID:8179792. |
the results suggested that the association of hva with prolonged hst may be related to central dopamine metabolism, but its association with similarities scores may be due to noradrenergic metabolism. |
1994-06-15 |
2023-08-12 |
Not clear |
| B Rundquist, G Eisenhofer, N A Dakak, M Elam, F Waagstein, P Friber. Cardiac noradrenergic function one year following cardiac transplantation. Blood pressure. vol 2. issue 4. 1994-06-06. PMID:8173693. |
to further characterize cardiac noradrenergic function (synthesis and metabolism) arterial and coronary venous plasma concentrations of the na precursor, dihydroxyphenylalanine (dopa), the dopamine metabolite, dihydroxyphenylacetic acid (dopac), and the intra-neuronal na metabolite, dihydroxyphenylglycol (dhpg), were also examined. |
1994-06-06 |
2023-08-12 |
human |
| J K Stewart, T G Campbell, T D Gbadebo, N Narasimhachari, J W Mannin. Cardiovascular responses and central catecholamines in streptozocin-diabetic rats. Neurochemistry international. vol 24. issue 2. 1994-05-25. PMID:8161945. |
in all diabetic rats spinal ratios of mhpg/norepinephrine (an index of noradrenergic activity) were higher than in nondiabetics, and the change in heart rate (post-surgical-pre-surgical rate) correlated inversely with hypothalamic dopamine (r = -0.60). |
1994-05-25 |
2023-08-12 |
rat |
| J Meek, H W Jooste. Tyrosine hydroxylase-immunoreactive cell groups in the brain of the teleost fish Gnathonemus petersii. Journal of chemical neuroanatomy. vol 6. issue 6. 1994-05-05. PMID:7908204. |
tyrosine hydroxylase-immunoreactive neurons were observed not only in clearly dopaminergic regions (the suprachiasmatic nucleus, the magnocellular hypothalamic nucleus and the area postrema) and noradrenergic cell groups (the locus coeruleus and inferior reticular cell group), but also in regions that do not, or only fragmentarily, display dopamine or noradrenaline immunoreactivity, including the ventral and intermediate telencephalon, the anterior and posterior preoptic cell group, the ventromedial thalamus, the pretectal region and the nucleus of the solitary tract, suggesting that they either represent depleted dopaminergic cell groups or l-dihydroxy phenylalanine-producing nuclei. |
1994-05-05 |
2023-08-12 |
Not clear |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in parkinson's disease and congenital dopamine beta-hydroxylase deficiency. |
1994-05-04 |
2023-08-12 |
human |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
dopamine beta-hydroxylase is stored and released with catecholamines by exocytosis from secretory vesicles in noradrenergic neurons and chromaffin cells. |
1994-05-04 |
2023-08-12 |
human |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
although dopamine beta-hydroxylase enzymic activity is measurable in cerebrospinal fluid, such activity is unstable, and its relationship to central noradrenergic neuronal activity in humans is not clearly established. |
1994-05-04 |
2023-08-12 |
human |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
to explore the significance of cerebrospinal fluid dopamine beta-hydroxylase, we applied a homologous human dopamine beta-hydroxylase radioimmunoassay to cerebrospinal fluid, in order to characterize the properties and stability of cerebrospinal fluid dopamine beta-hydroxylase, as well as its relationship to central noradrenergic neuronal activity and its variation in disease states such as hypertension, renal failure, parkinsonism and congenital dopamine beta-hydroxylase deficiency. |
1994-05-04 |
2023-08-12 |
human |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
cerebrospinal fluid dopamine beta-hydroxylase was not changed by the central alpha 2-agonist clonidine at a dose that diminished cerebrospinal fluid noradrenaline, nor did cerebrospinal fluid dopamine beta-hydroxylase correspond between subjects to cerebrospinal fluid concentrations of noradrenaline or methoxyhydroxyphenylglycol; thus, cerebrospinal fluid dopamine beta-hydroxylase concentration was not closely linked either pharmacologically or biochemically to central noradrenergic neuronal activity. |
1994-05-04 |
2023-08-12 |
human |
| D T O'Connor, J H Cervenka, R A Stone, G L Levine, R J Parmer, R E Franco-Bourland, I Madrazo, P J Langlais, D Robertson, I Biaggion. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical science (London, England : 1979). vol 86. issue 2. 1994-05-04. PMID:8143425. |
we conclude that cerebrospinal fluid dopamine beta-hydroxylase immunoreactivity, while not closely linked to central noradrenergic neuronal activity, is at least in part derived from the central nervous system, and that its measurement may be useful in both the diagnosis and treatment of neurological disease. |
1994-05-04 |
2023-08-12 |
human |